Serum

<a href="https://optimisus.com/news/crypto-news/former-ftx-exchange-executives-will-be-sentenced-after-pleading-guilty/">FTX exchange</a> is contesting a $264 million claim by Jump Trading subsidiary Tai Mo Shan for 800 million Serum (SRM) tokens obtained through a loan agreement with Alameda Research.   
The collapse of FTX in 2022 led to the decline of Serum, a decentralized exchange that used SRM as its native cryptocurrency. Jump Trading seeks compensation using an options model considering SRM's market price, volatility, and other financial factors.   
FTX's legal team argues that Alameda Research failed to fulfill the loan agreement by not delivering the SRM tokens, denying Tai Mo Shan's claim. FTX disputes the $264 million damages amount, arguing that it has a solid basis and is not clearly defined.   
The options model technique used by Jump Trading has been called into question, and suspicions of fraudulent transfers are also raised. <a href="https://optimisus.com/news/ftx-crypto-exchange-and-the-irs-reach-a-885-million-settlement/">The exchange</a> is formulating a liquidation strategy to compensate exchange clients amid ongoing legal disputes. 
The post <a href="https://optimisus.com/news/crypto-news/ftx-disputes-the-264-million-claim-by-jump-trading-over-srm-tokens/">FTX disputes the $264 million claim by Jump Trading over SRM tokens</a> appeared first on <a href="https://optimisus.com">Optimisus</a>.

FTX disputes the $264 million claim by Jump Trading over SRM tokens

Optimisus

Other articles published on Jul 12, 2024

Prepare for Altcoin Season: Grow Your Portfolio 40-100X

Monthly Wrap-Up April 2024: Web3 Festival & Tech Updates

Asia, Africa See Rise In Share Of Crypto Startups This Year, Says Accelerator

Here is the Next Big Thing for Cardano (ADA) Price: Will XRP Price Follow the Suit?

Critical Tokens for a Well-Rounded Crypto Wallet

Final signoff on spot Ether ETFs expected imminently, listings next week — Source

Join our free newsletter for daily crypto updates!